3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
4
Sponsor Class
OTHER
4
Study Type
Observational
3
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
3
Genitourinary
1
Conditions
Prostatic Neoplasms
11
Breast Neoplasms
10
Neoplasms
4
Osteoporosis
2
Melanoma
2
Cardiovascular Diseases
2
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Regional Osteoporosis as a Result of Chemotherapy
1
Primary Ovarian Insufficiency
1
Polycystic Ovary Syndrome
1
Paraganglioma, Extra-Adrenal
1
Pain
1
Oropharyngeal Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Monoclonal Gammopathy of Undetermined Significance
1
Metabolic Syndrome
1
Menstruation Disturbances
1
Lymphedema
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Neoplasms
1
Hematopoietic and Lymphoid System Neoplasm
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Depression
1
Cognitive Dysfunction
1
Interventions
Surveys and Questionnaires
114
Exercise
103
Blood Specimen Collection
99
Radiotherapy
67
Gemcitabine
64
Bevacizumab
57
Standard of Care
56
Cisplatin
55
Cyclophosphamide
51
Capecitabine
50
Carboplatin
49
Docetaxel
47
pembrolizumab
46
Dexamethasone
46
Paclitaxel
45
Interviews as Topic
43
Oxaliplatin
40
Magnetic Resonance Spectroscopy
39
Fluorouracil
37
Methods
36
Irinotecan
36
Therapeutics
33
Drug Therapy
33
Radiosurgery
31
Nivolumab
30
Erlotinib Hydrochloride
27
Educational Status
26
Everolimus
24
Leucovorin
23
Control Groups
23
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasms
×
Absorptiometry, Photon
×
Clear all
NCT03690401
2024-10-28
PostSOZO
Prisma Health-Upstate
Completed
52 enrolled
NCT03784911
2024-10-28
DuringSOZO
Prisma Health-Upstate
Completed
51 enrolled
NCT01641172
2024-04-19
TASTY
University Medical Center Groningen
Phase 4
Completed
140 enrolled
NCT02806154
2023-07-19
FRACTION
University Hospital, Toulouse
Completed
144 enrolled